Moderna (MRNA) revenue

Revenue · fiscal 2025
$1.92B

Moderna (MRNA) reported revenue of $1.92B in fiscal 2025 (the year ended December 31, 2025). That is 39.9% lower than the $3.20B of fiscal 2024. Figures as of 18 Nov 2026, 11:42 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$1.92B
Change on fiscal 2024
−39.9%
Growth, 5 years
+19.1% a year
Highest on record
$18.88Bfiscal 2022
Lowest on record
$60.21Mfiscal 2019
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Moderna revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 19.1% a year. Across the 10 fiscal years on record (2016–2025), the highest was $18.88B in fiscal 2022 and the lowest $60.21M in fiscal 2019.

History · 10 fiscal years

Revenue by fiscal year

Moderna revenue, year by year

Moderna (MRNA) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$1.92B 39.9% down
2024$3.20B 52.6% down
2023$6.75B 64.2% down
2022$18.88B 2.2% up
2021$18.47B 2,200.2% up
2020$803.00M 1,233.7% up
2019$60.21M 55.4% down
2018$135.07M 34.4% down
2017$205.83M 89.9% up
2016$108.40M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Moderna and comparable companies
CompanyRevenueFiscal year
McKesson MCK$403.43B2026
Sanofi SNY€46.72B2025
Moderna MRNA$1.92B2025
CVS Health CVS$402.07B2025
HCA Healthcare HCA$75.60B2025
GSK GSK£32.67B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MRNA

Moderna, figure by figure

Moderna (MRNA) overview: price, valuation and scorecardAll health care companies by market value

Moderna revenue: questions and answers

What is Moderna's revenue?

Moderna (MRNA) reported revenue of $1.92B in fiscal 2025 (the year ended December 31, 2025). That is 39.9% lower than the $3.20B of fiscal 2024.

What is the growth rate of Moderna's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 19.1% a year.

What are the highest and lowest revenue figures on record for Moderna?

Across the 10 fiscal years on record (2016–2025), the highest was $18.88B in fiscal 2022 and the lowest $60.21M in fiscal 2019.

How is Moderna's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Moderna it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Moderna (MRNA) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/MRNA/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.